
PI Industries (PIIND) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
17.9B
Gross Profit
9.8B
55.07%
Operating Income
3.8B
21.13%
Net Income
3.3B
18.49%
Balance Sheet Metrics
Total Assets
122.8B
Total Liabilities
21.2B
Shareholders Equity
101.6B
Debt to Equity
0.21
Cash Flow Metrics
Revenue & Profitability Trend
PI Industries Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 79.8B | 76.1B | 64.6B | 53.0B | 45.2B |
Cost of Goods Sold | 37.7B | 38.8B | 36.0B | 29.2B | 26.1B |
Gross Profit | 42.1B | 37.3B | 28.6B | 23.8B | 19.1B |
Gross Margin % | 52.7% | 49.1% | 44.3% | 44.8% | 42.4% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 2.8B | 2.2B | 2.1B | 1.4B |
Other Operating Expenses | 12.0B | 7.5B | 5.8B | 7.5B | 3.8B |
Total Operating Expenses | 12.0B | 10.3B | 8.0B | 9.6B | 5.2B |
Operating Income | 18.7B | 17.4B | 13.3B | 9.4B | 8.5B |
Operating Margin % | 23.4% | 22.9% | 20.6% | 17.7% | 18.8% |
Non-Operating Items | |||||
Interest Income | - | 1.3B | 848.0M | 671.0M | 552.0M |
Interest Expense | 330.0M | 300.0M | 371.0M | 128.0M | 281.0M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 21.4B | 18.9B | 14.4B | 10.3B | 9.4B |
Income Tax | 4.8B | 2.1B | 2.1B | 1.9B | 2.0B |
Effective Tax Rate % | 22.5% | 11.3% | 14.9% | 18.3% | 21.3% |
Net Income | 16.6B | 16.8B | 12.3B | 8.4B | 7.4B |
Net Margin % | 20.8% | 22.1% | 19.0% | 15.9% | 16.3% |
Key Metrics | |||||
EBITDA | 25.7B | 21.8B | 16.8B | 12.5B | 11.2B |
EPS (Basic) | ₹109.44 | ₹110.85 | ₹81.06 | ₹55.65 | ₹49.92 |
EPS (Diluted) | ₹109.42 | ₹110.83 | ₹81.04 | ₹55.63 | ₹49.89 |
Basic Shares Outstanding | 151699561 | 151692458 | 151675740 | 151626235 | 147899278 |
Diluted Shares Outstanding | 151699561 | 151692458 | 151675740 | 151626235 | 147899278 |
Income Statement Trend
PI Industries Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 5.9B | 8.9B | 8.7B | 3.5B | 1.1B |
Short-term Investments | 31.8B | 30.6B | 23.5B | 19.1B | 22.0B |
Accounts Receivable | 14.1B | 9.3B | 7.7B | 8.7B | 7.0B |
Inventory | 9.8B | 13.0B | 14.0B | 14.2B | 10.5B |
Other Current Assets | 3.6B | 3.1B | 1.9B | 167.0M | 168.0M |
Total Current Assets | 69.5B | 66.8B | 56.6B | 49.6B | 44.9B |
Non-Current Assets | |||||
Property, Plant & Equipment | 33.2B | 29.5B | 24.9B | 23.3B | 20.2B |
Goodwill | 16.1B | 10.4B | 2.6B | 2.5B | 2.4B |
Intangible Assets | 5.0B | 3.2B | 982.0M | 874.0M | 737.0M |
Long-term Investments | - | 288.0M | - | 273.0M | 192.0M |
Other Non-Current Assets | 197.0M | 544.0M | 188.0M | 125.0M | 146.0M |
Total Non-Current Assets | 53.2B | 40.9B | 28.2B | 28.3B | 25.1B |
Total Assets | 122.8B | 107.6B | 84.8B | 77.9B | 70.0B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 12.1B | 11.5B | 8.4B | 9.2B | 8.0B |
Short-term Debt | 604.0M | 851.0M | 141.0M | 1.2B | 870.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 1.0B | 998.0M | 735.0M | 300.0M | 307.0M |
Total Current Liabilities | 17.3B | 17.1B | 11.8B | 13.5B | 12.6B |
Non-Current Liabilities | |||||
Long-term Debt | 1.2B | 1.1B | 324.0M | 2.0B | 2.9B |
Deferred Tax Liabilities | 551.0M | 202.0M | 213.0M | 875.0M | 796.0M |
Other Non-Current Liabilities | - | -10.0M | - | - | - |
Total Non-Current Liabilities | 3.9B | 3.2B | 994.0M | 3.2B | 4.0B |
Total Liabilities | 21.2B | 20.3B | 12.8B | 16.7B | 16.6B |
Equity | |||||
Common Stock | 152.0M | 152.0M | 152.0M | 152.0M | 152.0M |
Retained Earnings | - | 61.9B | 47.1B | 36.9B | 29.2B |
Treasury Stock | - | 17.0M | 26.0M | 33.0M | 51.0M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 101.6B | 87.3B | 72.0B | 61.2B | 53.4B |
Key Metrics | |||||
Total Debt | 1.8B | 1.9B | 465.0M | 3.2B | 3.7B |
Working Capital | 52.2B | 49.7B | 44.8B | 36.2B | 32.4B |
Balance Sheet Composition
PI Industries Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 21.4B | 18.9B | 14.4B | 10.3B | 9.4B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | 0 | -31.0M |
Working Capital Changes | -3.7B | 1.3B | 2.6B | -6.4B | -3.5B |
Operating Cash Flow | 15.8B | 19.3B | 16.6B | 3.4B | 5.6B |
Investing Activities | |||||
Capital Expenditures | -8.4B | -6.2B | -3.2B | -3.4B | -4.4B |
Acquisitions | -3.6B | -6.3B | 0 | 0 | 0 |
Investment Purchases | -9.6B | -10.2B | -5.2B | -1.5B | -24.2B |
Investment Sales | 5.0B | 3.2B | 2.6B | 3.1B | 4.0B |
Investing Cash Flow | -16.5B | -19.5B | -5.8B | -1.8B | -24.5B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -2.3B | -1.7B | -1.1B | -758.0M | -607.0M |
Debt Issuance | 149.0M | 248.0M | 0 | 0 | 1.1B |
Debt Repayment | -341.0M | 0 | -2.7B | -720.0M | -1.8B |
Financing Cash Flow | -2.5B | -1.5B | -3.8B | -1.5B | 17.4B |
Free Cash Flow | 5.6B | 14.2B | 11.8B | 1.9B | 2.9B |
Net Change in Cash | -3.1B | -1.7B | 7.0B | 103.0M | -1.5B |
Cash Flow Trend
PI Industries Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
35.84
Forward P/E
29.82
Price to Book
5.85
Price to Sales
7.45
PEG Ratio
29.82
Profitability Ratios
Profit Margin
20.81%
Operating Margin
20.45%
Return on Equity
17.58%
Return on Assets
9.91%
Financial Health
Current Ratio
4.02
Debt to Equity
1.81
Beta
0.40
Per Share Data
EPS (TTM)
₹109.34
Book Value per Share
₹669.53
Revenue per Share
₹525.88
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
piind | 594.5B | 35.84 | 5.85 | 17.58% | 20.81% | 1.81 |
Coromandel | 712.9B | 31.54 | 6.42 | 18.41% | 8.56% | 6.95 |
UPL | 622.8B | 3.00 | 1.63 | 2.01% | 0.09% | 105.06 |
UPL | 565.8B | 50.76 | 1.99 | 2.01% | 2.55% | 66.35 |
Sumitomo Chemical | 288.1B | 51.80 | 9.93 | 17.40% | 16.55% | 1.79 |
Bayer CropScience | 247.6B | 41.72 | 8.69 | 19.93% | 10.29% | 3.69 |
Financial data is updated regularly. All figures are in the company's reporting currency.